A prospective, single arm, multicenter clinical trial of Pyrotinib combined with Bevacizumab and Capeox regimen in the treatment of advanced HER2-positive colorectal cancer
收藏NIAID Data Ecosystem2026-03-12 收录
官方服务：
资源简介：
Interventions: Case series: Pyrotinib combined with Bevacizumab and Capeox regimen Primary outcome(s): Objective remission rate Study Design: Single arm
创建时间：
2021-03-15
